Ipratropium Bromide and Salbutamol is used to treat bronchospasm (narrowing of the airways) associated with chronic obstructive pulmonary disease (COPD) and asthma. It is available in the form of a metered-dose inhaler (MDI) and nebulizer solution.

COPD

Asthma

The usual adult dose is 1 to 2 puffs of the MDI or 2.5 mL of the nebulizer solution four times a day.

Common side effects of Ipratropium Bromide and Salbutamol include dry mouth, throat irritation, headache, upper respiratory infection, nasopharyngitis, cough, bronchitis, headache, and dyspnea.

Dry Mouth

URTI (Upper Respiratory Tract Infection)

Nasopharyngitis

Headache

• Drowsiness and dizziness: Ipratropium Bromide and Salbutamol may cause drowsiness and dizziness. Do not drive or operate heavy machinery until you know how this medication affects you.

• Cardiovascular effects: Ipratropium Bromide and Salbutamol may cause an increase in heart rate and blood pressure. If you have a history of heart disease, consult your doctor before using this medication.

• Glaucoma: Ipratropium Bromide and Salbutamol may cause an increase in intraocular pressure and should be used with caution in patients with glaucoma.

• Thyroid disease: Ipratropium Bromide and Salbutamol may exacerbate symptoms of hyperthyroidism. Consult your doctor before using this medication if you have thyroid disease.

• Pregnancy and breastfeeding: Ipratropium Bromide and Salbutamol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known if Ipratropium Bromide and Salbutamol passes into breast milk. Consult your doctor before breastfeeding.

• Drug interactions: Ipratropium Bromide and Salbutamol may interact with other medications you are taking. Be sure to tell your doctor about all the medications you are taking, including prescription and non-prescription drugs, vitamins, and herbal supplements.